Statera Biopharma’s foundation is based on restoring immune health through the leveraging of complex, pleiotropic beneficial effects. At Statera, they embrace the idea that beneficial and safe drugs act as natural analogs in a paracrine fashion, as well as a trans-activator to resolve disease and elicit homeostasis.

Biotechnology

Statera BioPharma

Michael K. Handley

Curt D.

Cliff Selsky

Chris Zosh

Statera BioPharma's Board of Directors includes Satish Chandran.

Board of Directors

About

Team members

Other teams at Statera BioPharma

CEO and Executive Team

Leadership Team